atepeq/tico19 huggingface dataset:
The mRNAs are gene transcripts of the last third of the virus genome after the initial overlapping reading frame.
Ba mRNA eza bagene batranscrire na moko ya misato ya suka ya ba genome ya virusi sima ya bomatani ya yambo na botangi ya cadre.
These mRNAs are translated by the host's ribosomes into the structural proteins and a number of accessory proteins.
Ba mRNA yango ebongolami na moyambi ya ba ribosome kati ya ba proteine structurale na ndambo ya proteine accessoire.
RNA translation occurs inside the endoplasmic reticulum.
Bobongoli ya ARN esalamaka na kati ya reticulum endoplasmiki.
The viral structural proteins S, E, and M move along the secretory pathway into the Golgi intermediate compartment.
Baprotéine ya structure ya virusi S, E, pe M ekendeke na nzela ya emoniseli kuna na kati ya disuku ya kati ya Golgi .
There, the M proteins direct most protein-protein interactions required for assembly of viruses following its binding to the nucleocapsid.
Na kati kuna, ba proteine M etindaka bosangani mingi-mingi ya baproteine bango na bango mpóna kokangisa bavirusi sima ya bobatami naye na nucleocapside.
Progeny viruses are then released from the host cell by exocytosis through secretory vesicles.
Ba virusi ya mbotama sima ekendeke na cellule ya boyambi na exocytosis na nzela ya secretion ya bavesicule.
The interaction of the coronavirus spike protein with its complement host cell receptor is central in determining the tissue tropism, infectivity, and species range of the virus.
Bosangani ya barayon ya proteine ya coronavirusi na moyambi ya kobakisa naye eza kati penza mpóna koyeba batissu tropisme, bokotisi kpokoso, na espece ya virusi.
The SARS coronavirus, for example, infects human cells by attaching to the angiotensin-converting enzyme 2 (ACE2) receptor.
Coronavirusi ya SRAS, na ndakisa, etandaka kpokoso na bacellule ya bato na bokangami na ba recepteur ya ba enzyme 2 ya angiotensine-ya bobaloli (ACE2).
The scientific name for coronavirus is Orthocoronavirinae or Coronavirinae.
Kombo ya bakundoli ya mayele mpóna Coronavirusi ezali Orthocoronavirinae to Coronavirinae.
Coronaviruses belong to the family of Coronaviridae, order Nidovirales, and realm Riboviria.
Ba Coronavirusi bazali na libota ya Coronaviridae, molongo ya ba Nidovirale, pe domaine ya Riboviria.
Genus Betacoronavirus; type species: Murine coronavirus
Genre Betacoronavirusi; type ya ba espece: Coronavirusi ya Murine
Species: Betacoronavirus 1 (Bovine Coronavirus, Human coronavirus OC43), Human coronavirus HKU1, Murine coronavirus, Pipistrellus bat coronavirus HKU5, Rousettus bat coronavirus HKU9, Severe acute respiratory syndrome-related coronavirus (SARS-CoV, SARS-CoV-2), Tylonycteris bat coronavirus HKU4, Middle East respiratory syndrome-related coronavirus, Hedgehog coronavirus 1 (EriCoV)
Ba espece: Betacoronavirusi 1 (coronavirusi ya Ngúlu, coronavirusi ya Bato OC43), coronavirusi ya Bato HKU1, coronavirusi ya Murine, coronavirusi ya ngembo Pipistrellus HKU5, coronavirusi ya ngembo Rousettus HKU9, coronavirusi ekangani na ba syndrome-ya pasi ya pema (SARS-CoV, SARS-CoV-2), coronavirusi ya ngembo Tylonycteris HKU4, coronavirusi ya syndrome ya pema ya Moyen Orient, coronavirusi 1 Hedgehog (EriCoV)
Species: Beluga whale coronavirus SW1, Infectious bronchitis virus
Ba espece: coronavirusi ya balaine Beluga SW1, infection ya virusi ya bronchite
The most recent common ancestor (MRCA) of all coronaviruses is estimated to have existed as recently as 8000 BCE, although some models place the common ancestor as far back as 55 million years or more, implying long term coevolution with bat and avian species.
Nkóko ya mikolo mokuse mileki (MRCA) ekangisi bango bacoronavirusi nionso ekaniselami kozala kala mingi te na ba mbula 8000 BCE, kasi nde ba modele mosusu etiaka nkoko ya bango nionso kala mingi penza na mibu ba million 55 to molai, elingi koloba bokoli ya espece ya ngembo na avian.
The most recent common ancestor of the alphacoronavirus line has been placed at about 2400 BCE, the betacoronavirus line at 3300 BCE, the gammacoronavirus line at 2800 BCE, and the deltacoronavirus line at about 3000 BCE.
Nkóko ya mikolo eleki ekangisi bango na molongo ya alphacoronavirusi etiamami molai ya kala toloba na 2400 BCE, molongo ya betacoronavirusi na 3300 BCE, molongo ya gammacoronavirusi na 2800 BCE, pe molongo ya deltacoronavirusi na toloba 3000 BCE.
The large number of host bat and avian species, and their global range, has enabled extensive evolution and dissemination of coronaviruses.Many human coronavirus have their origin in bats.
Lotángo monene ya ba especeya ngembo-bayambi na ba avian, pe na molongo na bango ya mokili mobimba, epesi nzela na bokoli monene na bopalangani ya ba coronavirusi. Ba coronavirusi mingi ya bato ewutaki na bangembo.
More recently, alpaca coronavirus and human coronavirus 229E diverged sometime before 1960.
Na ntango mokuse eleki, coronavirusi ya alpaka pe coronavirusi ya bato 229E ekabwanaki na ba1960.
MERS-CoV emerged in humans from bats through the intermediate host of camels.
MERS-CoV eye kobimela na bato ewuti na ngembo na boleki nzela ya bapunda.
MERS-CoV, although related to several bat coronavirus species, appears to have diverged from these several centuries ago.
MERS-CoV, ta ko ekangani na ba espece ya coronavirusi ebele, emonani ete ekabwanaka ba siècle mingi eleki.
The most closely related bat coronavirus and SARS-CoV diverged in 1986.
Ba coronavirusi ya ngembo na ya SRAS-CoV ekangami na mikolo mike mileki ekabwanaki na 1986.
A possible path of evolution, of SARS coronavirus and keen bat coronaviruses, suggests that SARS related coronaviruses coevolved in bats for a long time.
Nzela ekaniselami na bokoli ya coronavirusi SRAS pe ba coronavirusi ya ngembo, elakisi ete ba coronavirusi ekangani na SRAS ebimaki elongo na ngembo kala mingi.
In the 1790s, equine coronavirus diverged from the bovine coronavirus after a cross-species jump.
Na mibu 1790, coronavirusi ya nvalu ewutaki na bangulu sima ya bokatisi kati ya ba espece.
Later in the 1890s, human coronavirus OC43 diverged from bovine coronavirus after another cross-species spillover event.
Na sima, na mibu 1890s, coronavirusi ya bato OC43 ekendaka nzela mosusu longwa na coronavirusi ya ngulu sima ya bofunmpuki ya bokatisi ya ba espece.
It is speculated that the flu pandemic of 1890 may have been caused by this spillover event, and not by the influenza virus, because of the related timing, neurological symptoms, and unknown causative agent of the pandemic.
Ezo kanisama ete pandemi ya grippe ya 1890 esalamaki na ntina ya etumba ya bofunmpuki, kasi na virusi ya malili te, na ntina ya tango ekanganaki, basymptome ya virologie, na eloko ebendaka pandemi eyebani te.
Human coronavirus OC43 besides causing respiratory infections is also suspected of playing a role in neurological diseases.
Coronavirusi ya bato OC43 libanda ya kopesa infection ya kopema eza pe kokaniselama kotia pasi na kobéla ya misisa.
In the 1950s, the human coronavirus OC43 began to diverge into its present genotypes.
Na mibu 1950s, coronavirusi ya bato OC43 ebandaki kokende nzela ekoma genotype ya lelo.
Phylogentically, mouse hepatitis virus (Murine coronavirus), which infects the mouse's liver and the central nervous system, is related to human coronavirus OC43 and bovine coronavirus.
Na bolandi nzela ya Phylogenetiki, virusi ya hepatite ya mpuku (coronavirusi Murine), mutu etiaka infection na libale pe systeme ya misisa ya centre, eza na bokangani na coronavirusi ya bato OC43 pe coronavirusi ya ngulu.
Human coronavirus HKU1, like the aforementioned viruses, also has its origins in rodents.
coronavirusi ya bato HKU1, lokola ba virusi elobilami likolo, lisusu ezali na bowuti nango na bampuku.
Coronaviruses vary significantly in risk factor.
Ba coronavirusi ekesanaka mingi na likama ebendaka.
Some can kill more than 30% of those infected, such as MERS-CoV, and some are relatively harmless, such as the common cold.
Ndámbo nango eko koboma koleka 30% ya bato babelaka yango, ndakisa MERS-CoV, pe ndambo ya baye bazangaka kpokoso ndakisa malili bato mingi babelaka.
Coronaviruses can cause colds with major symptoms, such as fever, and a sore throat from swollen adenoids.
Ba coronavirusi eko kopesa malili na basymptome makasi, lokola fievre, pe pasi na mongongo mpóna kovimba ya ba adenoide.
Coronaviruses can cause pneumonia (either direct viral pneumonia or secondary bacterial pneumonia) and bronchitis (either direct viral bronchitis or secondary bacterial bronchitis).
Ba coronavirusi eko kobenda panzi (ezala panzi ya virusi ya libela to panzi ya babacteria secondaire) pe bronchite (ezala bronchite ya virusi ya libela to bronchite ya babacteria secondaire).
The human coronavirus discovered in 2003, SARS-CoV, which causes severe acute respiratory syndrome (SARS), has a unique pathogenesis because it causes both upper and lower respiratory tract infections.Six species of human coronaviruses are known, with one species subdivided into two different strains, making seven strains of human coronaviruses altogether.
coronavirusi ya bato ekundolamaki na 2003, SRAS-CoV, mutu ebendaka basyndrome ya makasi ya kopema (SRAS), eza na pathogene ya yemoko na ntina ete ebendaka mibale ya kpokoso ya likolo pe ya se ya nzela ya kopemela. Ba espece motoba ya ba coronavirusi ya bato eyebani, espece moko ekabwani na basouche ya ndenge mibale, esalaka basouche sambo na nionso ya ba coronavirusi ya bato.
Four of these coronaviruses continually circulate in the human population and produce the generally mild symptoms of the common cold in adults and children worldwide: -OC43, -HKU1, HCoV-229E, -NL63.
Mine ya bacoronavirusi etambolaka mbala na mbala kati ya bato pe ebotaka basymptome ya pasi penza te ya malili ya bato banso ya bakolo na ya bana mike mokili mobimba : -OC43, -HKU1, HCoV-229E, -NL63.
Coronaviruses cause about 15% of commons colds.
Ba coronavirusi ebendaka toloba 15% ya malili ya bato banso.
The majority of colds are caused by rhinoviruses.
Mingi penza ya bamalili ebendamaka na barhinovirusi.
The four mild coronaviruses have a seasonal incidence occurring in the winter months in temperate climates.
Ba coronavirusi minei ya pete ebetaka batu na ba saison bongo eyaka basanza ya malili ya balimboli temperé.
There is no preference towards a particular season in tropical climates.
Boponi ezali te na likambo etali ba saison ya baclimat ya tropique .
Four human coronaviruses produce symptoms that are generally mild:
Ba coronavirusi minei ebimisaka míngi-mingi basymptome ya pete:
The virus was officially named the SARS coronavirus (SARS-CoV).
virusi óyo loyalo apesaka yango Kombo ya SRAS coronavirusi (SARS-CoV).
More than 8,000 people were infected, about ten percent of whom died.
Koleka bato 8,000 bazwaki infection, toloba ba pourcent zomi ya bango bakufaki.
In September 2012, a new type of coronavirus was identified, initially called Novel Coronavirus 2012, and now officially named Middle East respiratory syndrome coronavirus (MERS-CoV).
Na Septemba 2012, type ya coronavirusi ya sika emonanaki, liboso epesamaki nkombo ya coronavirusi Yasika 2012, pe sik’óyo loyalo abengi yango coronavirusi ya syndrome ya pema ya Moyen Orient (MERS-CoV).
The World Health Organization issued a global alert soon after.
OMS abimisaki liyebisi ya mokili mobimba noki-noki sima na yango.
The WHO update on 28 September 2012 said the virus did not seem to pass easily from person to person.
Mis a jour ya OMS ya 28 Septemba 2012 elobaki ete virusi ezangaki bokasi ya koleka pasi te na moto na moto.
However, on 12 May 2013, a case of human-to-human transmission in France was confirmed by the French Ministry of Social Affairs and Health.
Kási, na 12 Mai 2013, cas moko ya moto-apesi-moto endimamaki na France na ministere ya misala ya Bato na Santé ya Bato ya France.
In addition, cases of human-to-human transmission were reported by the Ministry of Health in Tunisia.
Na kobakisa, ba cas moko ya moto-apesi-moto esalamaki lapolo na Ministere ya Santé ya Tunisia.
Two confirmed cases involved people who seemed to have caught the disease from their late father, who became ill after a visit to Qatar and Saudi Arabia.
Mibale ya ba cas etali bato bakaniselaki bazwaki infection na tatá nabango mutu akufelaki yango tángo ya bokomi kobéla sima ya visite na Qatar pe Arabia Saudita.
Despite this, it appears the virus had trouble spreading from human to human, as most individuals who are infected do not transmit the virus.
Longola óyo, ezo monana lokola virusi ebandaki na pasi penza na bopalangani na moto-apesi-moto, lokola bato mingi bazalaka na infection bapesaka yango na moto te.
The final name for the virus is Middle East respiratory syndrome coronavirus (MERS-CoV).
Kombo ya suka mpóna virusi eza coronavirusi ya syndrome ya kopema ya Moyen Orient (MERS-CoV).
The only U.S. cases (both survived) were recorded in May 2014.In May 2015, an outbreak of MERS-CoV occurred in the Republic of Korea, when a man who had traveled to the Middle East, visited four hospitals in the Seoul area to treat his illness.
Ba cas kaka ya E.U., (mibale kasi babikaki) bakomamaki na Mai 2014. Na Mai 2015, kobéla ya MERS-CoV ebimaki na Republika ya Korea, tángo moto moko akendaki mobémbo na Moyen Orient, avisitaki balopitalo minei na Seoul mpo asalisa kobéla naye.
This caused one of the largest outbreaks of MERS-CoV outside the Middle East.
Óyo nde ebimisaki moko ya mikakatano ya monene mingi penza ya MERS-CoV libanda ya Moyen Orient .
As of December 2019, 2,468 cases of MERS-CoV infection had been confirmed by laboratory tests, 851 of which were fatal, a mortality rate of approximately 34.5%.
Na Decemba 2019, 2,468 ya ba cas ya infection ya MERS-CoV eyaki kondimama na batesite ya laboratoire, 851 na yango ebomaki, to ya koboma ya ngambo 34.5%.
In December 2019, a pneumonia outbreak was reported in Wuhan, China.
Na Decemba 2019, infection a panzi ebimaki na Wuhan, Chine.
On 31 December 2019, the outbreak was traced to a novel strain of coronavirus, which was given the interim name 2019-nCoV by the World Health Organization (WHO), later renamed SARS-CoV-2 by the International Committee on Taxonomy of Viruses.
Na 31 Decemba 2019, mokakatano ekanganaki na lolenge ya sika ya coronavirusi, yango nde epesamaki nkombo ya 2019-nCoV na Organization Mondiale ya Santé (OMS), sima ebengamaki SRAS-CoV-2 na Comité International ya Taxonomie ya Ba virusi.
Some researchers have suggested the Huanan Seafood Wholesale Market may not be the original source of viral transmission to humans.As of 17 April 2020, there have been at least 153,822 confirmed deaths and more than 2,240,191 confirmed cases in the coronavirus pneumonia pandemic.
Bakundoli baike bakanisi baloba ete Zándo ya Kompaní ya Botekeli Bambisi ya Mái na gros ya Huanan ekoki nango te kozala esika ya yambo ya bopesi ya virusi na bato. Na 17 Avril 2020, eyaki koyebana ete bato bakufaki bandimamaki lotango 153,822 ebongo koleka 2,240,191 endimamaki na ba cas ya pandemie ya panzi ya coronavirusi .
The Wuhan strain has been identified as a new strain of Betacoronavirus from group 2B with approximately 70% genetic similarity to the SARS-CoV.
Souche ya Wuhan esi emonani ete eza lolenge ya sika ya Betacoronavirusi ewúta na liboke 2B na ngambo ya 70% ya bokokani ya genetiki na SRAS-CoV.
The virus has a 96% similarity to a bat coronavirus, so it is widely suspected to originate from bats as well.
virusi óyo ekokani 96% na coronavirusi ya ngembo, yango wana ekaniselami mingi kowúta lisusu na bangembo.
The pandemic has resulted in travel restrictions and nationwide lockdowns in several countries.
Pandemie esúkeli na bopekisi bato batíka mibembo pe bikolo bikangama na bandáko na bikolo ebele.
Coronaviruses have been recognized as causing pathological conditions in veterinary medicine since the 1930s.
Ba coronavirusi basi bayébana ndenge babéndaka pasi ya pathologie na mambi ma medecine baveterinaire banda ba 1930.
Except for avian infectious bronchitis, the major related diseases have mainly an intestinal location.
Longola ba infection ya bronchite ya avian, mabela monene makangani mingi-mingi mazalaka kati ya mitsiopo.
Coronaviruses primarily infect the upper respiratory and gastrointestinal tract of mammals and birds.
Ba coronavirusi na liboso penza batiaka infection na likolo ya nzelá ya pema pe nzelá ya kifundu pe mitsiopo ya ba mamele na bandeke.
They also cause a range of diseases in farm animals and domesticated pets, some of which can be serious and are a threat to the farming industry.
Bapesaka pe molongo ya mabela na bibwele ya ferme na bibwele ya ndako, ndambo na yango eko kozala ya pasi makasi pe ezalaka moniokoli na industrie ya bafermier.
In chickens, the infectious bronchitis virus (IBV), a coronavirus, targets not only the respiratory tract but also the urogenital tract.
Na basoso, virusi ya bopesi infection ya bronchite(IBV), coronavirusi, ekendeke libela na nzelá kaka ya kopema te kasi pe na nzelá ya masúba.
The virus can spread to different organs throughout the chicken.
virusi ekokí kopalangana na bangambo mosusu na ba organe ya soso.
Economically significant coronaviruses of farm animals include porcine coronavirus (transmissible gastroenteritis coronavirus, TGE) and bovine coronavirus, which both result in diarrhea in young animals.
Mpo na mombóngo ya bafermier moniokoli ya ntina ya bacoronavirusi etie nakati coronavirusi ya ngúlu (coronavirusi gastroenteritite ekabolamaka, TGE) coronavirusi ya ngombe, mibale nango epesaka pulupulu na bibwele ya mike.
Feline coronavirus: two forms, feline enteric coronavirus is a pathogen of minor clinical significance, but spontaneous mutation of this virus can result in feline infectious peritonitis (FIP), a disease associated with high mortality.
Coronavirusi ya niawu: ndenge mibale, coronavirusi enteriki ya niawu ezalaka pathogene ya pasi te na cliniki, kasi nde mutation spontanée ya virusi yango eko kobenda infection ya peritonitite (FIP), kobéla mutu ebomaka mingi.
Similarly, there are two types of coronavirus that infect ferrets: Ferret enteric coronavirus causes a gastrointestinal syndrome known as epizootic catarrhal enteritis (ECE), and a more lethal systemic version of the virus (like FIP in cats) known as ferret systemic coronavirus (FSC).
Lolenge moko, ba ndenge mibale ya coronavirsi ebendaka infection na ba ferreti: Coronavirusi enteriki ya ferreti ebendaka syndrome gastrointestinali eyebani na nkombo ya epizootiki catarrhale enteritis (ECE), pe version systemiki moko ya virusi yango ebomaka mingi (ndakisa FIP na baniawu) babengi coronavirusi systemiki ya ferreti (FSC).
There are two types of canine coronavirus (CCoV), one that causes mild gastrointestinal disease and one that has been found to cause respiratory disease.
Bandenge eza mibale ya coronavirusi ya bacanine (CCoV), moko nango ebendaka kobéla ya gastrointestinale ya pete pe moko emonani epesaka kobéla ya pema.
Mouse hepatitis virus (MHV) is a coronavirus that causes an epidemic murine illness with high mortality, especially among colonies of laboratory mice.
virusi ya hepatite ya mpuku (MHV) eza coronavirusi ebimisaka maladie ya epidemie ya mpuku ya taux ya koboma ya likolo na mangomba ya ba mpuku ya laboratoire.
Sialodacryoadenitis virus (SDAV) is highly infectious coronavirus of laboratory rats, which can be transmitted between individuals by direct contact and indirectly by aerosol.
virusi ya Sialodacryoadenitis (SDAV) eza coronavirusi ya bampuku ya laboratoire epesaka infection ya makasi penza, mutu eko kolekisama na moto-na-moto na kosimba libela pe libela te na aerosole.
Some strains of MHV cause a progressive demyelinating encephalitis in mice which has been used as a murine model for multiple sclerosis.
Ba lolenge kamwa ya MHV ebendaka encephalitite demyelinating ya malembe na bampuku óyo basalelaki mpóna modele ya mpuku mpóna sclerose multiple.
Significant research efforts have been focused on elucidating the viral pathogenesis of these animal coronaviruses, especially by virologists interested in veterinary and zoonotic diseases.
Maluki makasi ya ntina matie miso mingi na bobakisi moi na bapathogene ya virusi coronavirusi ya nyama yango, mingi penza na bavirologiste balingi koyeba mambi ma mabela ya baveterinaire na bazoonotiki.
Porcine coronavirus (transmissible gastroenteritis coronavirus of pigs, TGEV).
coronavirusi ya ngúlu (coronavirusi gastroenteritite ya bangúlu ekabolamaka, TGEV).
Bovine coronavirus (BCV), responsible for severe profuse enteritis in of young calves.
coronavirusi ya ngombe (BCV), ememaka mokumba ya botie infection ya pasi mingi ya enterite ya bana ngúlu.
Feline coronavirus (FCoV) causes mild enteritis in cats as well as severe Feline infectious peritonitis (other variants of the same virus).
Coronavirusi ya banianwu (FCoV) ebendaka infection ya pete ya enterite na baniawu elongo na infection makasi ya peritonite (bavariant mosusu ya virusi ya ndenge moko).
the two types of canine coronavirus (CCoV) (one causing enteritis, the other found in respiratory diseases).
ba coronavirusii mibale ya canine (CCoV) (moko epesaka enterite, mosusu emonani na pasi ya pema).
Turkey coronavirus (TCV) causes enteritis in turkeys.
coronavirusii ya autriche (TCV) ebendaka enteritite na ba autriche.
Ferret enteric coronavirus causes epizootic catarrhal enteritis in ferrets.
coronavirusii enteriki ya ferreti ebendaka enteritite epizootiki catarrhale na baferreti.
Ferret systemic coronavirus causes FIP-like systemic syndrome in ferrets.
coronavirusii systemiki ya ferreti ebendaka syndrome systemiki ekokani na FIP na baferreti.
Rabbit enteric coronavirus causes acute gastrointestinal disease and diarrhea in young European rabbits.
coronavirusii enteriki ya nlumba ebendaka kobéla pasi ya gastrointestinale na pulu-pulu na bana nlumba ya Europa.
Porcine epidemic diarrhea virus (PED or PEDV), has emerged around the world.
virusii ya epidemiki ya pulu-pulu ya ngulu(PED to PEDV), esi ebimi na mokili.
b'Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Mabela ya b'Coronavirusi ya 2019 (COVID-19) ezali pasi ya infection ya mabela ebendami na coronavirusi 2 ya syndrome ya songe ya bopemi (SRAS-CoV-2).
Common symptoms include fever, cough, and shortness of breath.
Ba symptome ya ba tango mingi etie nakati fievre, kosukosu, na pema bokuse.
Other symptoms may include fatigue, muscle pain, diarrhea, sore throat, loss of smell, and abdominal pain.
Ba symptome mosusu eko kotía nakati kolemba, misuni pasi, pulu-pulu, mongongo pasi, koyóka solo, libumu pasi.
The time from exposure to onset of symptoms is typically around five days but may range from two to fourteen days.
Bandá bozwi ti bobandi ya basymptome eza ngambo ya mikolo mitano kasi eko komata mikolo mibale ti zomi na minei.
While the majority of cases result in mild symptoms, some progress to viral pneumonia and multi-organ failure.
Ba cas mingi ezalaka nango na basymptome ya pete, kasi mosusu esukaka na panzi mabe pe kopola ya ba organe.
As of 17 April 2020, more than 2.24 million cases have been reported across 210 countries and territories, resulting in more than 153,000 deaths.
Na 17 Avril 2020, koleka ba million 2.24 ya ba cas esi epesami lapolo na bikólo pe bingunda 210, mutu esúkeli na liwâ ya bato koleka 153,000.
More than 568,000 people have recovered.The virus is primarily spread between people during close contact, often via small droplets produced by coughing, sneezing, or talking.
Koleka lotango ya bato 568,000 bazongi konungonu. yango virusi mingi-mingi epalanganaka kati ya bato baza na ngambo, mingi-mingi na biteni mike-mike ya nsoi ebimaka na kokosola, kosala kesia to koloba.
While these droplets are produced when breathing out, they usually fall to the ground or onto surfaces rather than being infectious over long distances.
Biténi ya nsoi yango ebimaka pe tángo ya kopema, kasi mingi-mingi ekwéyaka na mabelé to esika ya ngambo ezalaka na infection ya bobwakami mosika te.
People may also become infected by touching a contaminated surface and then touching their eyes, nose, or mouth.
Bato pe bako kokoma na infection soki bazali kosimba bisika eza contaminé pe sima basimbi miso, zolo, to monoko na bango.
The virus can survive on surfaces up to 72 hours.
virusii eko kozala ya bomoi na esika tii bangonga 72.
It is most contagious during the first three days after the onset of symptoms, although spread may be possible before symptoms appear and in later stages of the disease.The standard method of diagnosis is by real-time reverse transcription polymerase chain reaction (rRT-PCR) from a nasopharyngeal swab.
Ezalaka na motungisi makasi mikolo misato ya yambo ya ebandeli ya basymtome, kasi bopalangani eko kozala nango liboso basymtome emonana pe na ntango ya sima ya maladi. Methode standarde ya diagnostiki eza na reaction na chaine ya bozongi sima na temps reel ya bokomi ya polymerase (rRT-PCR) na swabi sima ya zolo.
The use of masks is recommended for those who suspect they have the virus and their caregivers.
Bosáleli ya masike na elongi etindami mpóna bato bazo kanisela bango baza na virusi pe bakengeli na bango.
Recommendations for mask use by the general public vary, with some authorities recommending against their use, some recommending their use, and others requiring their use.
Etindi ya bosaleli ya masike na bato banso na publiki ekesani, na ntina ete bakonzi mosusu bazo boya basalela yango, basusu bazo tinda yango, pe basusu bazo loba esengeli basalela yango.
Currently, there is no vaccine or specific antiviral treatment for COVID-19.
Mikolo ya lelo, vaccin to kisi ya kobelesa COVID-19 ezali te.
Local transmission of the disease has been recorded in most countries across all six WHO regions.
Bokaboli ya esika moko ya maladi esi ekomami na ebele ya bikolo na bingunda nyónso motóba ya OMS.
Those infected with the virus may be asymptomatic or develop flu-like symptoms such as fever, cough, fatigue, and shortness of breath.
Bato bazwi infection ya virusi bakoki kozala asymptomatiki to bako kokolisa basymtome ekokani na óyo ya grippe, ndakisa fievre, kosu-kosu, kolemba, pema mokuse.
Emergency symptoms include difficulty breathing, persistent chest pain or pressure, confusion, difficulty waking, and bluish face or lips; immediate medical attention is advised if these symptoms are present.
Ba symptome ya bombango etie nakati kopema na pasi, pasi ezo sila te kati ya tolo to pression, kobunga makanisi, kolamoka na pasi, pe elongi to mbebo ekomi bule; kenge ya monganga noki eluki botosi soki basymptome ya boye eza.
Less commonly, upper respiratory symptoms such as sneezing, runny nose or sore throat may be seen.
Bambala mike, basymptome ya pema ya likolo lokola ba kesia, kotanga zolo to pasi na mongongo eko kozala.
Gastrointestinal symptoms such as nausea, vomiting and diarrhoea have been observed in varying percentages.
Ba symptome gastrointestinale lokola posa ya kosanza, kosanza pe pulu-pulu esi emonani na porcentage ekesani.
Some cases in China initially presented only with chest tightness and palpitations.
Ba cas mosusu na Chine na ebandeli elakisaki kaka tolo kokanga pe motema kobeta.
In some, the disease may progress to pneumonia, multi-organ failure, and death.
Na bato mosusu, kobéla eko kokoma pasi ya panzi, ba organe ebele eko kopola, pe liwa.
This is called the incubation period.
óyo ebengamaka ntango ya incubation.
The incubation period for COVID-19 is typically five to six days but may range from two to 14 days.
Ntngo ya incubation mpóna COVID-19 eza mingi-mingi mikolo mitano ti motoba kasi range mikolo mibale ti 14.
97.5% of people who develop symptoms will do so within 11.5 days of infection.Reports indicate that not all who are infected develop symptoms.
97.5% ya bato bazwaka basymtome bamonaka yango kati ya mikolo 11.5 ya bozwi infection. Ba lapolo elakisi bato banso ya infection te babimaka basymtome.
The role of these asymptomatic carriers in transmission is not yet fully known; however, preliminary evidence suggests that they may contribute to the spread of the disease.
Ntína ya bamemi asymptomatiki yango na bokaboli naino eyebani mobimba penza te; kasi nde bilembo ya ebandeli ekaniseli ete baza na mosala na bopanzi kobéla.
The proportion of infected people who do not display symptoms is currently unknown and being studied, with the Korea Centers for Disease Control and Prevention (KCDC) reporting that 20% of all confirmed cases remained asymptomatic during their hospital stay.
Ndámbo ya lotango ya bato ya infection baye balakisaka basymptome te sik’oyo eyebani te pe ezo yekolama, na bacentre ya Korea mpóna Controle pe bopekisi ya Makono (KCDC) epesi lapolo ete 20% ya bacas nyónso baconfirmaki eza kaka asymptomatiki na bofandi na lopitalo.
China's National Health Commission began including asymptomatic cases in its daily cases on 1 April; of the 166 infections on that day, 130 (78%) were asymptomatic at the time of testing.
Comission Nationale ya Santé ya Chine esi ebandi kotia nakati bacas asymptomatiki na bacas ya moko-na-mokolo na 1 April; na 166 ya bakwoso nyónso ya mokolo wana, 130 (78%) ezalaki asymptomatiki na ntango ya tesite.
Both sputum and saliva can carry large viral loads.
Milelu na nsoi eko kozala na kilo monene ya virusi.
Loud talking releases more droplets than normal talking.
Koloba ya makasi elekaka matanga mingi na koloba ya normale.
A study in Singapore found that an uncovered cough can lead to droplets travelling up to 4.5 meters (15 feet).
Liyekoli moko ya Singapore emoni ete kosu-kosu ezangi bozipi eko komema matanga na 4.5 metres (15 pied).
Though the virus is not generally airborne, the National Academy of Science has suggested that bioaerosol transmission may be possible and air collectors positioned in the hallway outside of people's rooms yielded samples positive for viral RNA.
Atako virusi yango mingi-mingi ebotamaka nango na mopepe te, Academy National ya Science elobi bokabli na bioaerosol nde eko kosalama pe bikongoli ya mopepe na bacoridore libanda ya masuku ya bato epesi ba echantillon ya positife mpóna virusi RNA.
Some medical procedures such as intubation and cardiopulmonary resuscitation (CPR) may cause respiratory secretions to be aerosolised and thus result in airborne spread.
Ba operation ya monganga mosusu lokola kotia tiyo na kati pe Resisitasio Cardiopulmonaire(CPR) ekoki kosala ete matanga ya kopema ekota na mopepe bongo kopanzana na mopepe.
While there are concerns it may spread via feces, this risk is believed to be low.The virus is most contagious when people are symptomatic; while spread may be possible before symptoms emerge, the risk is low.
Souci eza ete eko kopalangana na niei, likama yango ezo ndimama na niveau yase. virusii ezalaka makasi mingi na bokabwani soki bato baza symptomatiki; ta ko bopalangani eko kosalama liboso basymptome ebima, likama eza nase.
The European Centre for Disease Prevention and Control (ECDC) says while it is not entirely clear how easily the disease spreads, one person generally infects two to three others.The virus survives for hours to days on surfaces.
Centre ya Europa mpóna Controle pe Bopekisi ya Maladie (ECDC) elobi ta ko eyebani penza na moi te ndenge nini eza pasi te maladi epalangana, moto moko mingi-mingi apesaka kpokoso na bato mibale to misato mosusu. virusii ekoki kowumela ba ngonga molai na likolo ya biloko.
Specifically, the virus was found to be detectable for one day on cardboard, for up to three days on plastic (polypropylene) and stainless steel (AISI 304), and for up to four hours on 99% copper.
Na specifiki, virusi emonanaki kowumela likolo ya carton mokolo mobimba, tii mokolo misato na plastiki (polypropylene) pe ebendé ezanga rouille (AISI 304), pe tii bangonga minei na 99% ya cuivre.
This, however, varies depending on the humidity and temperature.
Kasi, yango nde ekesanaka na botali humidité pe température.
Soap and detergent are also effective if correctly used; soap products degrade the virus' fatty protective layer, deactivating it, as well as freeing them from skin and other surfaces.
Savo pe detergent ezalaka pe makasi soki esalameli lolenge elongobani; ba produit ya savo ekataka poso ya mafúta ebatelaka virusi, elongolaka bango, elongo na kolongola yango na poso to bisika mosusu.
Other solutions, such as benzalkonium chloride and chlorhexidine gluconate (a surgical disinfectant), are less effective.In a Hong Kong study, saliva samples were taken a median of two days after the start of hospitalization.
Basolution mosusu, lokola chloride ya benzalkonium pe gluconate ya chlorhexidine (desinfectant ya chirurgie), eza pete. Na boyekoli ya Hong Kong, ba echantillon ya nsoi bakongolaki kati ya mikolo mibale sima ya bokoti lopitalo.
In five of six patients, the first sample showed the highest viral load, and the sixth patient showed the highest viral load on the second day tested.
Na mitano ya babeli motoba, echantillon ya liboso elakisi kilo ya virusi emata na nsuka, ebongo mobeli ya motoba azalaki na kilo ya virusi emata mokolo ya mibale ya tesite.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel severe acute respiratory syndrome coronavirus, first isolated from three people with pneumonia connected to the cluster of acute respiratory illness cases in Wuhan.
Syndrome ya pasi mingi ya pema ya coronavirusi 2 (SRAS-CoV-2) eza coronavirusi ya sika ya pasi makasi ya syndrome ya kopema, elongolamaki mbala liboso na bato misato babelaki panzi ekangana na bato ya pasi makasi ya pema na Wuhan.
All features of the novel SARS-CoV-2 virus occur in related coronaviruses in nature.
Bikilakila nionso ya virusi ya sika SRAS-CoV-2 ezalaka na bacoronavirusi ekangana na mokili.
Outside the human body, the virus is killed by household soap, which bursts its protective bubble.SARS-CoV-2 is closely related to the original SARS-CoV.
Libanda ya nzoto ya moto, virusi ebomamaka na savon ya ndáko, mutu epasolaka boule ebatelaka yango. SRAS-CoV-2 ekangani mingi na SRAS-CoV ya ebandeli.
The lungs are the organs most affected by COVID-19 because the virus accesses host cells via the enzyme angiotensin-converting enzyme 2 (ACE2), which is most abundant in the type II alveolar cells of the lungs.
Mipululu mizali ba organe ezwaka mingi kpokoso ewutaka na COVID-19 mpo virusi ekotaka na cellula eyambaka ye na nzela ya enzyme angiotensin-convertisant enzyme 2 (ACE2), mutu ezali mingi na bacellula alveole type II ya mampulu.
The virus uses a special surface glycoprotein called a "spike" (peplomer) to connect to ACE2 and enter the host cell.
virusi esalelaka surface speciale ya glycoproteine ebengamaka "spike" (peplomer) mpóna kokanga yango na ACE2 pe ekota na cellula moyambi.
Acute cardiac injury was found in 12% of infected people admitted in hospital in Wuhan, China, and is more frequent in severe disease.
Bozoki ya grave ya motema emonanaki na 12% ya bato ya kpokoso bakotisamaki na lopitalo na Wuhan, Chine, pe ezalaka mingi na maladi ya pasi makasi.
Rates of cardiovascular symptoms is high, owing to the systemic inflammatory response and immune system disorders during disease progression, but acute myocardial injury may also be related to ACE2 receptors in the heart.
Taux ya basymtome cardiovasculaire emata, eza mpóna reaction ya inflamation systemiki na pasi ya systemi immune ntango kobéla ezo kola, kasi bozoki ya songe ya myocardiaki eko pe kokangana na ba recepteur ya ACE2 na motema.
ACE2 receptors are highly expressed in the heart and are involved in heart function.
Ba recepteur ya ACE2 emonanaka mingi na motema pe esalisaka na bosali ya motema.
A high incidence of thrombosis (31%) and venous thromboembolism (25%) have been found in ICU patients with COVID-19 infections and may be related to poor prognosis.Autopsies of people who died of COVID-19 have found diffuse alveolar damage (DAD), and lymphocyte-containing inflammatory infiltrates within the lung.
Incidence ebuta ya thrombose (31%) pe thromboembolisme ya ba misisa monene (25%) emonani na ba malade ya USI baza na kpokoso ya COVID-19 pe eko kozala na bokangani na prognostiki ya bopoto. Mapasoli ma bakufa ya COVID-19 elakisi mbeba ya alveole diffuse(AAD), pe lymphocyte-eza na infiltrate inflammatoire nakati ya poumon.
Although SARS-COV-2 has a tropism for ACE2-expressing epithelial cells of the respiratory tract, patients with severe COVID-19 have symptoms of systemic hyperinflammation.
Ata ko SRAS-COV-2 eza na tropisme mpóna ACE2-expressing epithelial cells ya nzela ya kopemela, babeli ya COVID-19 ya makasi bazalaka na basymptome ya hyperinflammation systemiki.
In particular, pathogenic GM-CSF-secreting T-cells were shown to correlate with the recruitment of inflammatory IL-6-secreting monocytes and severe lung pathology in COVID-19 patients.
Na ebatiseli, na bacellula T ya GM-CSF-ebimisaka bapathogene elakisamaki ete ezali na correlation na recrutement ya bamoncyte IL-6 ebimisaka inflammasio pe pathologie ya pasi mabe ya lipili na malade ya COVID-19.
Lymphocytic infiltrates have also been reported at autopsy.
Ba infiltrate lymphocytiki esi esalameli lisusu lapolo na bopasoli.
The WHO has published several testing protocols for the disease.
OMS asi apublié baprotocole ebele ya tesite mpóna bokono yango.
The standard method of testing is real-time reverse transcription polymerase chain reaction (rRT-PCR).
Methode standarde mpóna bosalisi tesite eza bokomi na temps réel inverse ya reaction ya chaine ya polymerase (rRT-PCR).
The test is typically done on respiratory samples obtained by a nasopharyngeal swab; however, a nasal swab or sputum sample may also be used.
Tesite na particulié esalamelaka na ba echantillon ya pema bazwaka na bosaleli ya tige motongo ya zolo ti na mongongo; kasi bako kosalela pe tige ya zolo to echantillon ya crachat.
Results are generally available within a few hours to two days.
Baresulta ekoyebana mingi-mingi kati ya ba ngonga mike elandaka to na mikolo mibale.
Blood tests can be used, but these require two blood samples taken two weeks apart and the results have little immediate value.
Bakoki kosalela batesite ya makila, kasi yango esengaka ba echantillon mibale ya makila babendi baposo mibale ekabwana pe ba resultat ezangi valele moke ya noki-noki.
Chinese scientists were able to isolate a strain of the coronavirus and publish the genetic sequence so laboratories across the world could independently develop polymerase chain reaction (PCR) tests to detect infection by the virus.
Bakundoli ya Chine bazalaki na makoki ma ko isolé lolenge ya coronavirusi pe bapubliaki sequence genetiki bongo ba laboratoire ya mokili mobimba bakoka kokolisa na kimpwanza batesite ya reaction ya chaine polymerase (PCR) mpóna kodetecté kpokoso na virusi.
As of 4 April 2020, antibody tests (which may detect active infections and whether a person had been infected in the past) were in development, but not yet widely used.
Na 4 Avril 2020, tesite ya anticorps (mutu eko kodetecté bakpokoso ya actif pe soki moto asi azwaki kpokoso kala) ezalaki na bokolisi, kasi naino na bosaleli mingi te.
The Chinese experience with testing has shown the accuracy is only 60 to 70%.
Experience ya bato ya Chine na bosali ya tesite elakisi ete bosolo nayango eza kaka 60 ti 70%.
The FDA in the United States approved the first point-of-care test on 21 March 2020 for use at the end of that month.Diagnostic guidelines released by Zhongnan Hospital of Wuhan University suggested methods for detecting infections based upon clinical features and epidemiological risk.
FDA na Etats-Unis asi andimaki esika ya liboso ya bosali tesite ya depistage na 21 Mars 2020 po bato basalelaka na suka sanza. Milongo ya lisungi ya diagnostiki na Lopitalo ya Zhongnan ya Université ya Wuhan ekanisi ba methodi mpóna kodetecté ba kpokoso ose ya bikilakila ya cliniki pe likama ya epidemiologie.
Bilateral multilobar ground-glass opacities with a peripheral, asymmetric and posterior distribution are common in early infection.
Ba opacité ya multilbare ya kitala-tala ya mabele ngambo mibale na peripherique, asymetrique pe bokaboli ya sima emonanaka mingi na ba kpokoso ya yambo.
Subpleural dominance, crazy paving (lobular septal thickening with variable alveolar filling), and consolidation may appear as the disease progresses.
Dominance subpleurale, pavement ya liboma (kovimba ya lobe septale na botondisi ya alveole ekesanaka), pe consolidation eko komonana tango maladi ezo kola.
Few data are available about microscopic lesions and the pathophysiology of COVID-19.
Badonnée mike kaka esi ebimi etali ba lesion microscopiki pe pathophysiologia ya COVID-19.
The main pathological findings at autopsy are:
Makundoli ma principale na autopsia mazali::
Macroscopy: pleurisy, pericarditis, lung consolidation and pulmonary oedema
Macroscopia: pleuresie, pericarditite, consolidation ya lipili pe oedema ya lipululu.
Four types of severity of viral pneumonia can be observed:
Bandenge minei ya koswa ya pasi mingi na panzi eko komonana:
mild pneumonia: pulmonary oedema, pneumocyte hyperplasia, large atypical pneumocytes, interstitial inflammation with lymphocytic infiltration and multinucleated giant cell formation
panzi ya pete: panzi ya oedèma, hyperplasie pneumocyte, ba pneumocyte atypiki ya monene, inflammasio interstitiale na infiltration ya lymphocytiki pe formation ya cellula multinucleate ya kabakata
severe pneumonia: diffuse alveolar damage (DAD) with diffuse alveolar exudates.
panzi ya pasi makasi: bopanzani mabe ya alveole (DAD) bopanzani ya ba exudate ya alveole.
DAD is the cause of acute respiratory distress syndrome (ARDS) and severe hypoxemia.
DAD eza esika ewutaka syndrome ya pasi ya songe ya matáta ya kopema (ARDS) pe pasi mabe ya hypoxemie.
healing pneumonia: organisation of exudates in alveolar cavities and pulmonary interstitial fibrosis
bosilisi ya panzi: bobongisi ya ba exudate kati ya mabulu ya alveole pe fibrose ya lipili interstitiale.
Blood: disseminated intravascular coagulation (DIC); leukoerythroblastic reaction
Makila: bokangami na bopalangani ya makila na intravesicula (DIC); reactio ya leukoerythroblastiki
Preventive measures to reduce the chances of infection include staying at home, avoiding crowded places, washing hands with soap and water often and for at least 20 seconds, practising good respiratory hygiene and avoiding touching the eyes, nose or mouth with unwashed hands.
Ba mezile mpóna bopekisi pe bokitisi ya makama ya kozwa kpokoso etie nakati bofandi na ndako, bokimi ya bisika ya bato mingi, bosokoli maboko na savo na mai mbala mingi molai ba seconde 20, bosaleli ya peto ya pema pe kotika kosimba miso, zolo to monoko na maboko ya mbindo.
The CDC recommends covering the mouth and nose with a tissue when coughing or sneezing and recommends using the inside of the elbow if no tissue is available.
Botindi ya CDC ezali bozipi monoko na zolo na muswale tango ya bokosoli na bosali kesia pe ezo tinda bosaleli ya bogunzami ya liboko soki muswale ezangi.
Proper hand hygiene after any cough or sneeze is encouraged.
Bopéto ya solo sima ya bokosoli na bosali kesia esengami na molende.
The CDC has recommended the use of cloth face coverings in public settings, in part to limit transmission by asymptomatic individuals.Social distancing strategies aim to reduce contact of infected persons with large groups by closing schools and workplaces, restricting travel and cancelling large public gatherings.
CDC atindi bosaleli ya elámba mpóna kozipa elongi na publiki, na ndámbo mpóna kokáta bopalangani ya bato baza asymptomatiki. Bastrategie ya bobombi distance kati ya bato ebongisami mpóna kokitisa bosangani ya bato bazali na infection pe bokangí basikola pe bisika ya bosali, bopekisi mibémbo pe bokangí ya bisika bato ebele basanganaka.
Distancing guidelines also include that people stay at least 6 feet (1.8 m) apart.
Masungi ya bobombi distance pe etatoli ete bato batikala toloba 6 feet (1.8 m) na bokabwani.
There is no medication known to be effective at preventing COVID-19.As a vaccine is not expected until 2021 at the earliest, a key part of managing COVID-19 is trying to decrease the epidemic peak, known as "flattening the curve".
Kísi eza te óyo eyebani mpóna kopekisa na bokasi pasi ya COVID-19. Lokóla vaccin ezo zelama te esíla kosalama ti 2021 na elikia, ndámbo ya fungola mpóna kogéré COVID-19 eza komeka kokitisa songe ya ngomba ya epidemia, yango ebengami "kokómisa courbe platte".
The CDC also recommends that individuals wash hands often with soap and water for at least 20 seconds, especially after going to the toilet or when hands are visibly dirty, before eating and after blowing one's nose, coughing or sneezing.
CDC esengi bato basokola maboko ba mbala ebele na sabuni na mai mpóna baseconde 20, nsima ya kokenda na kabine to tango maboko ezo monana na mbindo, liboso ya kolia bilei; mpe nsima ya kopopola zolo, kokosola, mpe kosala kesia.
It further recommends using an alcohol-based hand sanitiser with at least 60% alcohol, but only when soap and water are not readily available.For areas where commercial hand sanitisers are not readily available, the WHO provides two formulations for local production.
Elandeli kotinda bosaleli ya biloko basala na alcoholi ya 60% mpóna kotia bopeto na maboko, kasi kaka tango savo na mayi ezali te. Na bisika biye bizalaka na mambi ma kosomba basanitiseur ya bopeto ya maboko óyo batekaka te, OMS ekotisi baformule ya bobotisi yango na esika.
In these formulations, the antimicrobial activity arises from ethanol or isopropanol.
Na baformula yango, bosali ya bobomi mikolobi etombokaka uta na ethanole to isopropanole.
Hydrogen peroxide is used to help eliminate bacterial spores in the alcohol; it is "not an active substance for hand antisepsis".
Basalelaka peroxide ya hydrogene mpóna kosalisa na bolongoli ya mabulu ya mikolobe na alcoholi; ezali "subistance elamuka te mpóna antisepsiki ya maboko".
Glycerol is added as a humectant.
Babakisaka glyceroli mpóna komouillé.
People are managed with supportive care, which may include fluid therapy, oxygen support, and supporting other affected vital organs.
Bato bazo salisama na ba soin ya lisungi mutu eko kotia nakati therapi ya bamai, lisungi ya oxygene, pe kosunga ba organe mosusu ezwá kpokoso.
The CDC recommends that those who suspect they carry the virus wear a simple face mask.
CDC azo tinda ete bato bazo kanisa bazo Mama virusi yango balataka masike ya sempele na elongi.
Extracorporeal membrane oxygenation (ECMO) has been used to address the issue of respiratory failure, but its benefits are still under consideration.
Bopesi oxygene na nzela ya membrane ya libanda ya nzoto (ECMO) esalameli mpóna kosilisa pasi ya pema mabe, kasi bolamo nango eza naíno na boyekoli.
Personal hygiene and a healthy lifestyle and diet have been recommended to improve immunity.
Bopeto ya moto ye moko na mode de vie pe diete ya bilei etindami mpóna kobongisa immunité.
Supportive treatments may be useful in those with mild symptoms at the early stage of infection.The WHO and Chinese National Health Commission have published recommendations for taking care of people who are hospitalised with COVID-19.
Lisungi na batraitement eko kozala na ntina mpóna bato baza na basymptome ya pete na tango ya ebandeli ya kopkoso. OMS na Comité Nationale ya Santé ya Chine basi bapublié mitindo mpóna kosalisa bato baza na mbéto ya lopitálo mpóna COVID-19.
Intensivists and pulmonologists in the U.S. have compiled treatment recommendations from various agencies into a free resource, the IBCC.
Ba intensiviste na ba pulmonologue na E.U. basi babongisi mitindo ya traitement ewuti na ba agence ya ndenge na ndenge na ba resource ya ofele, IBCC.
As of April 2020, there is no specific treatment for COVID-19.
Na sanza ya Avril 2020, traitement specifiki ezangi mpóna COVID-19.
For symptoms, some medical professionals recommend paracetamol (acetaminophen) over ibuprofen for first-line use.
mpóna basymptome, minganga mosusu bazo tinda bosaleli ya paracetamol (acetaminophene) esika ya ibuprofene na etumba ya ebandeli.
Precautions must be taken to minimise the risk of virus transmission, especially in healthcare settings when performing procedures that can generate aerosols, such as intubation or hand ventilation.
Baprecaution esengeli ezwama mpóna kokitisa likama ya bokaboli ya virusi, mingi-mingi na bisika ya minganga bazo pesa lisalisi óyo eko kobimisa ba aerosole lokola botie ya batiyo to mopepe ya kopepa na maboko.